Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed Nov 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$371K
Net Open-Market Flow
-$371K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 19, 2025Sell(S)3K$86.51$242K0
Nov 19, 2025Sell(S)2K$85.72$129K3K
Nov 19, 2025Option exercise(M)2K$7.14$15K2K
Nov 19, 2025Option exercise(M)2K$9.08$20K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 19, 2025Option exercise(M)2K—$024K
Nov 19, 2025Option exercise(M)2K—$024K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-115017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PALVELLA THERAPEUTICS, INC.

Build

Ask your agent about PVLA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-25-115017"
Ask your agent
Use Arkolith to summarize insider buying and selling at PALVELLA THERAPEUTICS, INC.
over the last 90 days and cite the filings.